Human Melanoma gp100 (PMEL) activation kit by CRISPRa
CAT#: GA104416
PMEL CRISPRa kit - CRISPR gene activation of human premelanosome protein
CNY 12,255.00
Cited in 1 publication. |
CNY 1,999.00
CNY 2,700.00
CNY 7,384.00
CNY 800.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | PMEL |
Locus ID | 6490 |
Kit Components | GA104416G1, Melanoma gp100 gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA104416G2, Melanoma gp100 gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA104416G3, Melanoma gp100 gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Disclaimer | These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc. |
Reference Data | |
RefSeq | NM_001200053, NM_001200054, NM_001320121, NM_001320122, NM_006928 |
Synonyms | D12S53E; gp100; ME20; ME20-M; ME20M; P1; P100; PMEL17; SI; SIL; SILV |
Summary | This gene encodes a melanocyte-specific type I transmembrane glycoprotein. The encoded protein is enriched in melanosomes, which are the melanin-producing organelles in melanocytes, and plays an essential role in the structural organization of premelanosomes. This protein is involved in generating internal matrix fibers that define the transition from Stage I to Stage II melanosomes. This protein undergoes a complex pattern of prosttranslational processing and modification that is essential to the proper functioning of the protein. A secreted form of this protein that is released by proteolytic ectodomain shedding may be used as a melanoma-specific serum marker. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011] |
Citations (1)
The use of this Gene Expression has been cited in the following citations: |
---|
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy
,null,
Science Advances
,PubMed ID 31844672
[PMEL]
|
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN400663 | PMEL - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8,680.00 |